These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 990072)

  • 1. Intracellular mucin production by lobular breast carcinoma cells.
    Breslow A; Brancaccio ME
    Arch Pathol Lab Med; 1976 Nov; 100(11):620-1. PubMed ID: 990072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
    Palacios J; Benito N; Pizarro A; Suárez A; Espada J; Cano A; Gamallo C
    Am J Pathol; 1995 Mar; 146(3):605-12. PubMed ID: 7534041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobular carcinoma of the breast with extracellular mucin: new variant of mucin-producing carcinomas?
    Rosa M; Mohammadi A; Masood S
    Pathol Int; 2009 Jun; 59(6):405-9. PubMed ID: 19490472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
    Tot T
    Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular localization of HMFG2 in breast carcinomas: an immunohistochemical and immunoelectron microscopic study.
    Hanna WM; Kahn HJ; Zive SE; Shackleton M; Andrighetti L
    Mod Pathol; 1992 Nov; 5(6):603-6. PubMed ID: 1369793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma.
    Gamallo C; Palacios J; Suarez A; Pizarro A; Navarro P; Quintanilla M; Cano A
    Am J Pathol; 1993 Apr; 142(4):987-93. PubMed ID: 7682767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of mucin 1 and tumor invasiveness in breast carcinoma].
    Gao P; Zhou GY; Zhang QH; Xiang L; Ma C; Yu HP; Yu F
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):381-4. PubMed ID: 15854526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
    Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
    Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BigH3 protein expression as a marker for breast cancer.
    Calaf GM; Echiburú-Chau C; Zhao YL; Hei TK
    Int J Mol Med; 2008 May; 21(5):561-8. PubMed ID: 18425347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectral morphometric characterization of breast carcinoma cells.
    Barshack I; Kopolovic J; Malik Z; Rothmann C
    Br J Cancer; 1999 Mar; 79(9-10):1613-9. PubMed ID: 10188915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinical study of lobular carcinoma of the breast].
    Tanaka T; Morimoto T; Komaki K; Yamakawa T; Mitsuyama N; Oshimo K; Onime Y; Monden Y
    Gan No Rinsho; 1987 Sep; 33(11):1309-13. PubMed ID: 3669317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of leptomeningeal carcinomatosis in carcinoma of the breast with infiltrating lobular carcinoma. An autopsy study.
    Lamovec J; Zidar A
    Arch Pathol Lab Med; 1991 May; 115(5):507-10. PubMed ID: 2021320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
    Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A
    Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucins in breast carcinoma.
    Hanna WM; Corkill M
    Hum Pathol; 1988 Jan; 19(1):11-4. PubMed ID: 2447006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases.
    Carter MR; Hornick JL; Lester S; Fletcher CD
    Am J Surg Pathol; 2006 Mar; 30(3):300-9. PubMed ID: 16538049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?
    Goldstein NS
    Am J Clin Pathol; 2002 Sep; 118(3):425-34. PubMed ID: 12219785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathologic analysis of lobular carcinoma of the breast--report of 36 cases].
    Qian H
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):278-81. PubMed ID: 2625110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
    Moll R; Mitze M; Frixen UH; Birchmeier W
    Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.